{"hands_on_practices": [{"introduction": "The transformation of dietary components by the gut microbiota into bioactive metabolites is a cornerstone of the gut-brain-immune axis. This exercise [@problem_id:2844276] provides a practical model to quantify this process, focusing on the production of short-chain fatty acids (SCFAs) from fermentable fiber. By applying principles of stoichiometry and mass balance, you will calculate how a change in diet alters the delivery of key SCFAs—acetate, propionate, and butyrate—to the portal circulation, providing a tangible link between nutrition and the pool of systemic neuroimmune signaling molecules.", "problem": "In a human colonic fermentation model relevant to the gut–brain axis and neuroimmune interactions, short-chain fatty acids (SCFAs) are produced from fermentable fiber by the gut microbiota with a stable stoichiometry: acetate, propionate, and butyrate account for fractions $0.60$, $0.20$, and $0.20$ of total SCFA molar production, respectively. Assume a linear yield with respect to fermentable fiber intake: each gram of fermentable fiber produces $2~\\mathrm{mmol}$ of total SCFAs. Of the SCFAs produced, a fixed fraction is delivered to the portal vein after accounting for luminal losses and colonocyte oxidation: $0.90$ for acetate, $0.60$ for propionate, and $0.30$ for butyrate. Consider a dietary change in which daily fermentable fiber intake increases from $10~\\mathrm{g/day}$ to $30~\\mathrm{g/day}$. Using conservation of mass and proportional allocation implied by the stoichiometry and fixed delivery fractions, derive the resulting change in portal SCFA delivery rates and report the increase as a row matrix $[\\Delta \\text{acetate}\\ \\Delta \\text{propionate}\\ \\Delta \\text{butyrate}]$ in $\\mathrm{mmol/day}$. Provide the final numerical values exactly as the row matrix entries in the specified order. No rounding is required.", "solution": "The problem statement is subjected to validation.\n\nGivens extracted verbatim from the problem statement:\n- Stoichiometric fractions of total SCFA molar production for acetate, propionate, and butyrate are $0.60$, $0.20$, and $0.20$, respectively.\n- Linear yield of total SCFAs from fermentable fiber: $2~\\mathrm{mmol}$ of total SCFAs per $1~\\mathrm{g}$ of fermentable fiber.\n- Portal vein delivery fractions: $0.90$ for acetate, $0.60$ for propionate, and $0.30$ for butyrate.\n- Initial daily fermentable fiber intake: $10~\\mathrm{g/day}$.\n- Final daily fermentable fiber intake: $30~\\mathrm{g/day}$.\n- The objective is to find the change in portal SCFA delivery rates, reported as a row matrix $[\\Delta \\text{acetate}\\ \\Delta \\text{propionate}\\ \\Delta \\text{butyrate}]$ in units of $\\mathrm{mmol/day}$.\n\nValidation Verdict:\nThe problem is deemed valid. It is scientifically grounded in a simplified but plausible model of colonic fermentation, which is a core topic in gut-brain axis research. The problem is well-posed, with all necessary parameters provided for a unique solution. It is objective, quantitative, and free of ambiguity or contradiction. It does not violate any of the specified invalidity criteria. Therefore, a solution will be derived.\n\nThe problem requires the calculation of the change in the daily delivery rate of each short-chain fatty acid (SCFA) to the portal vein, resulting from an increase in dietary fermentable fiber. The solution is a direct application of the principles of mass conservation and proportional allocation as described.\n\nLet $F_1$ be the initial daily fermentable fiber intake and $F_2$ be the final daily fermentable fiber intake.\nThe given values are:\n$F_1 = 10~\\mathrm{g/day}$\n$F_2 = 30~\\mathrm{g/day}$\n\nThe change in daily fiber intake, $\\Delta F$, is:\n$$ \\Delta F = F_2 - F_1 = 30~\\mathrm{g/day} - 10~\\mathrm{g/day} = 20~\\mathrm{g/day} $$\n\nThe problem states a linear yield, $Y$, of total SCFAs from fermentable fiber:\n$$ Y = 2~\\mathrm{mmol/g} $$\n\nThe change in total SCFA production, $\\Delta P_{\\text{total}}$, is the product of the change in fiber intake and the yield:\n$$ \\Delta P_{\\text{total}} = \\Delta F \\times Y = (20~\\mathrm{g/day}) \\times (2~\\mathrm{mmol/g}) = 40~\\mathrm{mmol/day} $$\n\nThis total change in production is distributed among acetate, propionate, and butyrate according to the given stoichiometric fractions. Let these fractions be $f_A$, $f_P$, and $f_B$ for acetate, propionate, and butyrate, respectively.\n$f_A = 0.60$\n$f_P = 0.20$\n$f_B = 0.20$\n\nThe change in the production rate for each individual SCFA ($\\Delta P_A$, $\\Delta P_P$, $\\Delta P_B$) is calculated by multiplying the total change in SCFA production by the respective stoichiometric fraction:\n$$ \\Delta P_A = \\Delta P_{\\text{total}} \\times f_A = (40~\\mathrm{mmol/day}) \\times 0.60 = 24~\\mathrm{mmol/day} $$\n$$ \\Delta P_P = \\Delta P_{\\text{total}} \\times f_P = (40~\\mathrm{mmol/day}) \\times 0.20 = 8~\\mathrm{mmol/day} $$\n$$ \\Delta P_B = \\Delta P_{\\text{total}} \\times f_B = (40~\\mathrm{mmol/day}) \\times 0.20 = 8~\\mathrm{mmol/day} $$\n\nNot all produced SCFAs reach the portal vein. The fraction delivered is given for each SCFA. Let these delivery fractions be $d_A$, $d_P$, and $d_B$.\n$d_A = 0.90$\n$d_P = 0.60$\n$d_B = 0.30$\n\nThe change in the portal delivery rate for each SCFA ($\\Delta D_A$, $\\Delta D_P$, $\\Delta D_B$) is the product of the change in its production rate and its specific delivery fraction:\n$$ \\Delta D_A = \\Delta P_A \\times d_A = (24~\\mathrm{mmol/day}) \\times 0.90 = 21.6~\\mathrm{mmol/day} $$\n$$ \\Delta D_P = \\Delta P_P \\times d_P = (8~\\mathrm{mmol/day}) \\times 0.60 = 4.8~\\mathrm{mmol/day} $$\n$$ \\Delta D_B = \\Delta P_B \\times d_B = (8~\\mathrm{mmol/day}) \\times 0.30 = 2.4~\\mathrm{mmol/day} $$\n\nThe final answer is to be presented as a row matrix of these changes: $[\\Delta D_A\\ \\Delta D_P\\ \\Delta D_B]$.\n$$ [\\Delta \\text{acetate}\\ \\Delta \\text{propionate}\\ \\Delta \\text{butyrate}] = [21.6\\ \\ 4.8\\ \\ 2.4]~\\mathrm{mmol/day} $$\nThe numerical values are exact as required.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n21.6 & 4.8 & 2.4\n\\end{pmatrix}\n}\n$$", "id": "2844276"}, {"introduction": "A signaling molecule's concentration is only half the story; its ability to activate a cellular response depends on how effectively it binds to its target receptors. This practice [@problem_id:2844311] focuses on this crucial step, asking you to apply the principles of mass-action kinetics to calculate the equilibrium occupancy of the GPR43 receptor by its ligand, acetate. By determining the fraction of receptors bound at a given physiological concentration, $[L]$, relative to the receptor's affinity, $K_D$, you will gain a quantitative understanding of signal strength and its implications for modulating immune cell function within the neuroimmune network.", "problem": "A short-chain fatty acid produced by gut microbiota, acetate, signals through G protein-coupled receptor 43 (GPR43), also known as free fatty acid receptor 2 (FFAR2), expressed on neutrophils and other immune cells that participate in neuroimmune communication along the gut–brain axis. Consider circulating acetate at a steady-state concentration of $1~\\mathrm{mM}$ bathing neutrophils intravascularly. Assume the following conditions hold: the receptor–ligand system is at equilibrium; binding is $1{:}1$ without cooperativity; the free ligand concentration equals the total acetate concentration (protein binding is negligible); and there is no receptor reserve affecting the occupancy–response relationship.\n\nYou are given the equilibrium dissociation constant $K_D$ for acetate binding to GPR43 as $300~\\mu\\mathrm{M}$.\n\nUsing only the definition of the equilibrium dissociation constant and mass-action binding under the assumptions above, derive from first principles the equilibrium receptor occupancy (the fraction of total receptors bound by ligand) for GPR43 on neutrophils at the stated acetate concentration. Then, briefly interpret how the computed occupancy would be expected to influence neutrophil chemotaxis signaling through GPR43 within the gut–brain neuroimmune axis, noting whether signaling would be weak, moderate, or near-saturating in this context and the plausible direction of modulation of chemotactic responsiveness.\n\nExpress the final receptor occupancy as a decimal fraction with no unit, and round your final numerical answer to four significant figures.", "solution": "The problem as stated is subjected to validation.\n\nStep 1: Extracted Givens.\n-   Analyte: Acetate, a short-chain fatty acid.\n-   Receptor: G protein-coupled receptor 43 (GPR43), or free fatty acid receptor 2 (FFAR2).\n-   Cell Type: Neutrophils.\n-   Total acetate concentration, which is assumed to be equal to the free ligand concentration $[L]$: $1~\\mathrm{mM}$.\n-   Equilibrium dissociation constant, $K_D$: $300~\\mu\\mathrm{M}$.\n-   Assumptions:\n    1.  The system is at equilibrium.\n    2.  Binding is $1{:}1$.\n    3.  There is no cooperativity.\n    4.  Free ligand concentration equals total acetate concentration.\n    5.  There is no receptor reserve.\n-   Task:\n    1.  Derive the equilibrium receptor occupancy ($\\theta$) from first principles.\n    2.  Calculate $\\theta$ for the given acetate concentration.\n    3.  Interpret the result in the context of neutrophil chemotaxis signaling, classifying the signal strength and direction of modulation.\n    4.  Provide the final numerical answer as a decimal fraction rounded to four significant figures.\n\nStep 2: Validation.\nThe problem is scientifically grounded, well-posed, and objective. It is based on the fundamental principles of receptor pharmacology and mass-action kinetics. The biological context—acetate, GPR43, and neutrophil signaling in the gut–brain axis—is an established area of scientific research. The provided values for concentration ($[L]$) and the dissociation constant ($K_D$) are biologically plausible. The problem is self-contained, providing all necessary information and assumptions to derive a unique, meaningful solution. It does not violate any scientific principles, is not ambiguous, and presents a standard, non-trivial calculation and interpretation task appropriate for the field.\n\nStep 3: Verdict.\nThe problem is deemed valid. A solution will be furnished.\n\nThe equilibrium receptor occupancy, denoted by $\\theta$, is defined as the fraction of the total receptor population that is bound by a ligand at equilibrium. The total receptor concentration, $[R]_{total}$, is the sum of the free receptor concentration, $[R]$, and the ligand-bound receptor concentration, $[LR]$.\n$$[R]_{total} = [R] + [LR]$$\nBy definition, the receptor occupancy $\\theta$ is:\n$$\\theta = \\frac{[LR]}{[R]_{total}}$$\nThe binding of a ligand, $L$, to a receptor, $R$, to form a complex, $LR$, is described by the reversible reaction:\n$$L + R \\rightleftharpoons LR$$\nThe equilibrium dissociation constant, $K_D$, is defined for this reaction based on the law of mass action at equilibrium:\n$$K_D = \\frac{[L][R]}{[LR]}$$\nwhere $[L]$ is the free ligand concentration. We can rearrange this expression to solve for the free receptor concentration, $[R]$:\n$$[R] = \\frac{K_D [LR]}{[L]}$$\nNow, we substitute this expression for $[R]$ into the equation for the total receptor concentration:\n$$[R]_{total} = \\frac{K_D [LR]}{[L]} + [LR]$$\nTo simplify, we factor out the term $[LR]$:\n$$[R]_{total} = [LR] \\left( \\frac{K_D}{[L]} + 1 \\right)$$\nTo find the expression for occupancy, $\\theta$, we rearrange this equation to solve for the fraction $\\frac{[LR]}{[R]_{total}}$:\n$$\\theta = \\frac{[LR]}{[R]_{total}} = \\frac{1}{\\frac{K_D}{[L]} + 1}$$\nMultiplying the numerator and denominator by $[L]$ yields the final, standard form of the Hill-Langmuir equation for $1{:}1$ non-cooperative binding:\n$$\\theta = \\frac{[L]}{[L] + K_D}$$\nThis derivation from first principles is now complete.\n\nWe are given the following values:\nLigand concentration, $[L] = 1~\\mathrm{mM}$.\nEquilibrium dissociation constant, $K_D = 300~\\mu\\mathrm{M}$.\n\nFor the calculation, the units must be consistent. We convert millimolar ($mM$) to micromolar ($\\mu\\mathrm{M}$).\n$$[L] = 1~\\mathrm{mM} = 1 \\times 1000~\\mu\\mathrm{M} = 1000~\\mu\\mathrm{M}$$\nNow, we substitute the numerical values for $[L]$ and $K_D$ into the derived equation for $\\theta$:\n$$\\theta = \\frac{1000~\\mu\\mathrm{M}}{1000~\\mu\\mathrm{M} + 300~\\mu\\mathrm{M}} = \\frac{1000}{1300} = \\frac{10}{13}$$\nTo express this as a decimal fraction, we perform the division:\n$$\\theta = \\frac{10}{13} \\approx 0.7692307...$$\nRounding to four significant figures as required by the problem statement gives:\n$$\\theta \\approx 0.7692$$\n\nInterpretation:\nThe calculated receptor occupancy is approximately $0.7692$, meaning that at a steady-state acetate concentration of $1~\\mathrm{mM}$, about $77\\%$ of the GPR43 receptors on neutrophils are bound. The value of $K_D$ represents the ligand concentration required to achieve $50\\%$ occupancy. Since the given ligand concentration ($1000~\\mu\\mathrm{M}$) is more than threefold greater than the $K_D$ ($300~\\mu\\mathrm{M}$), the system is operating well above the half-maximal response point. Among the choices of weak, moderate, or near-saturating, this level of occupancy indicates a strong signal that is approaching saturation. While not fully saturated (which would imply occupancy greater than $90\\%$), it is significantly beyond a merely moderate response. Therefore, it is best classified as a response approaching saturation or simply a strong response.\n\nRegarding the direction of modulation, activation of GPR43 on neutrophils by short-chain fatty acids like acetate has been shown to modulate inflammatory responses, including chemotaxis. While context-dependent, a primary role of GPR43 activation is to prime neutrophils and potentiate their chemotactic response to other inflammatory cues, such as bacterial peptides or chemokines. Therefore, it is plausible that this high level of GPR43 engagement by acetate would enhance or potentiate neutrophil chemotaxis, thereby contributing to the regulation of immune cell trafficking within the gut-brain neuroimmune axis.", "answer": "$$\\boxed{0.7692}$$", "id": "2844311"}, {"introduction": "To truly understand the gut-brain axis, we must move from individual components to the behavior of the integrated system. This exercise [@problem_id:2844286] challenges you to do just that by building a dynamic mathematical model of the Hypothalamic-Pituitary-Adrenal (HPA) axis, a central regulator of the body's stress response. Using principles of systems biology, you will construct a set of ordinary differential equations (ODEs) that capture the HPA cascade and incorporate a key feature of neuroimmune interactions: the influence of gut inflammation. Solving for the steady-state will reveal precisely how this peripheral signal alters systemic cortisol levels, offering a powerful insight into whole-body regulation.", "problem": "A minimal dynamical model of the Hypothalamic–Pituitary–Adrenal (HPA) axis can be constructed by tracking the concentrations of corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), and cortisol, denoted by $C(t)$, $A(t)$, and $F(t)$, respectively. In the gut–brain axis, inflammatory signals from the intestine increase hypothalamic drive, augmenting CRH release. Cortisol exerts negative feedback on both CRH and ACTH. Assume the following modeling principles grounded in first-principles mass balance and linearization around a homeostatic operating point:\n\n- For each species $X \\in \\{C,A,F\\}$, the rate of change satisfies $dX/dt = \\text{production} - \\text{first-order clearance}$.\n- Basal CRH production is $p_C$ and is augmented by a gut inflammation drive $G$ scaled by $k_G$; $G$ is an exogenous, constant, dimensionless input (normalized activity).\n- Cortisol imposes an effective linearized inhibitory influence on CRH and ACTH production, captured by terms proportional to $F(t)$ with proportionality constants $b_C$ and $b_A$, respectively. This linear influence is the local (first-order) approximation of a saturating negative feedback.\n- ACTH production is proportional to CRH with gain $p_A$, and cortisol production is proportional to ACTH with gain $p_F$.\n- First-order clearance rates are $k_C$, $k_A$, and $k_F$ for $C(t)$, $A(t)$, and $F(t)$, respectively.\n- All parameters $p_C$, $k_G$, $b_C$, $p_A$, $b_A$, $p_F$, $k_C$, $k_A$, $k_F$ are positive constants.\n\nTask:\n1) Using the principles above, write down a well-posed system of ordinary differential equations (ODEs) for $C(t)$, $A(t)$, and $F(t)$ that incorporates negative feedback of cortisol on CRH and ACTH and includes a term by which gut inflammation augments CRH release.\n2) Assuming a steady inflammatory drive $G$ that is constant in time, derive from first principles the steady-state cortisol concentration $F^{\\ast}$ as a closed-form analytic expression in terms of $G$ and the model parameters.\n3) Express your final answer solely as an explicit analytic expression for $F^{\\ast}$ in terms of $G$, $p_C$, $k_G$, $b_C$, $p_A$, $b_A$, $p_F$, $k_C$, $k_A$, and $k_F$. No numerical evaluation is required or permitted, and no rounding is necessary.", "solution": "The problem requires the formulation of a system of ordinary differential equations (ODEs) representing a simplified model of the Hypothalamic–Pituitary–Adrenal (HPA) axis under gut inflammatory influence, followed by the derivation of the steady-state cortisol concentration.\n\nFirst, I will validate the problem statement.\n\nStep 1: Extract Givens\n- Dependent variables (concentrations): $C(t)$ (CRH), $A(t)$ (ACTH), $F(t)$ (cortisol).\n- Independent variable: time $t$.\n- Input: $G$, a constant, dimensionless gut inflammation drive.\n- Parameters (all positive constants):\n  - $p_C$: Basal CRH production rate.\n  - $k_G$: Scaling factor for gut inflammation drive.\n  - $b_C$: Proportionality constant for cortisol's negative feedback on CRH production.\n  - $b_A$: Proportionality constant for cortisol's negative feedback on ACTH production.\n  - $p_A$: Gain constant for ACTH production from CRH.\n  - $p_F$: Gain constant for cortisol production from ACTH.\n  - $k_C$: First-order clearance rate for CRH.\n  - $k_A$: First-order clearance rate for ACTH.\n  - $k_F$: First-order clearance rate for cortisol.\n- Modeling Principles:\n  1. For any species $X \\in \\{C,A,F\\}$, the dynamics are given by $\\frac{dX}{dt} = \\text{production} - \\text{first-order clearance}$.\n  2. CRH production combines a basal rate $p_C$, an augmentation $k_G G$ from gut inflammation, and a negative feedback term $-b_C F(t)$.\n  3. ACTH production is stimulated by CRH (term $p_A C(t)$) and inhibited by cortisol (term $-b_A F(t)$).\n  4. Cortisol production is proportional to ACTH with gain $p_F$.\n  5. Clearance for each species $X$ is given by $k_X X(t)$.\n\nStep 2: Validate Using Extracted Givens\nThe problem is assessed for validity.\n- **Scientifically Grounded**: The problem describes a linearized model of the HPA axis, a well-studied biological system. The principles of feed-forward activation, negative feedback, production, and clearance are fundamental concepts in systems biology and endocrinology. The representation is a simplification but is based on established scientific principles. It is scientifically sound.\n- **Well-Posed**: The principles provided lead to a system of linear, first-order, non-homogeneous ordinary differential equations. The task is to write this system and then find its unique steady-state (equilibrium) solution. This is a standard and well-posed problem in mathematics and engineering.\n- **Objective**: The problem is stated using precise, formal language common in mathematical modeling, free of ambiguity or subjectivity.\n\nVerdict: The problem is scientifically grounded, well-posed, objective, and self-contained. There are no contradictions or missing information required to complete the specified tasks. The problem is valid.\n\nProceeding to the solution.\n\nTask 1: Formulate the system of ODEs.\nThe general form for each equation is $\\frac{dX}{dt} = \\text{Production}_X - \\text{Clearance}_X$.\n\nFor CRH, $C(t)$:\nThe production term includes basal production $p_C$, stimulation from gut inflammation $k_G G$, and negative feedback from cortisol, which is stated to be an inhibitory influence proportional to $F(t)$. Thus, production is $p_C + k_G G - b_C F(t)$. The clearance is a first-order process, given by $k_C C(t)$.\nThe resulting equation is:\n$$ \\frac{dC}{dt} = p_C + k_G G - b_C F(t) - k_C C(t) $$\n\nFor ACTH, $A(t)$:\nThe production is proportional to CRH concentration with gain $p_A$, giving a term $p_A C(t)$. Cortisol also imposes an inhibitory influence on ACTH production, represented by a term $-b_A F(t)$. The total production is therefore $p_A C(t) - b_A F(t)$. The clearance is a first-order process, $k_A A(t)$.\nThe resulting equation is:\n$$ \\frac{dA}{dt} = p_A C(t) - b_A F(t) - k_A A(t) $$\n\nFor Cortisol, $F(t)$:\nThe production is proportional to ACTH concentration with gain $p_F$, giving a term $p_F A(t)$. The problem statement does not specify any direct feedback on cortisol production itself. The clearance is a first-order process, $k_F F(t)$.\nThe resulting equation is:\n$$ \\frac{dF}{dt} = p_F A(t) - k_F F(t) $$\n\nThe complete system of ODEs is:\n$$\n\\begin{cases}\n\\frac{dC}{dt} = p_C + k_G G - b_C F - k_C C \\\\\n\\frac{dA}{dt} = p_A C - b_A F - k_A A \\\\\n\\frac{dF}{dt} = p_F A - k_F F\n\\end{cases}\n$$\n\nTask 2: Derive the steady-state cortisol concentration, $F^*$.\nAt steady state, the concentrations are constant, meaning their time derivatives are zero. Let the steady-state concentrations be denoted by $C^*$, $A^*$, and $F^*$.\n$$ \\frac{dC}{dt} = 0, \\quad \\frac{dA}{dt} = 0, \\quad \\frac{dF}{dt} = 0 $$\nThis transforms the system of ODEs into a system of linear algebraic equations:\n$$ (1) \\quad 0 = p_C + k_G G - b_C F^* - k_C C^* $$\n$$ (2) \\quad 0 = p_A C^* - b_A F^* - k_A A^* $$\n$$ (3) \\quad 0 = p_F A^* - k_F F^* $$\n\nWe will solve this system for $F^*$ by substitution, starting from equation $(3)$.\n\nFrom (3), we can express $A^*$ in terms of $F^*$:\n$$ p_F A^* = k_F F^* \\implies A^* = \\frac{k_F}{p_F} F^* $$\n\nNext, substitute this expression for $A^*$ into equation $(2)$ to find $C^*$ in terms of $F^*$:\n$$ 0 = p_A C^* - b_A F^* - k_A \\left( \\frac{k_F}{p_F} F^* \\right) $$\n$$ p_A C^* = b_A F^* + \\frac{k_A k_F}{p_F} F^* $$\nFactor out $F^*$ on the right-hand side:\n$$ p_A C^* = \\left( b_A + \\frac{k_A k_F}{p_F} \\right) F^* $$\nIsolate $C^*$:\n$$ C^* = \\frac{1}{p_A} \\left( b_A + \\frac{k_A k_F}{p_F} \\right) F^* = \\left( \\frac{b_A}{p_A} + \\frac{k_A k_F}{p_A p_F} \\right) F^* $$\n\nFinally, substitute the expression for $C^*$ into equation $(1)$:\n$$ 0 = p_C + k_G G - b_C F^* - k_C C^* $$\n$$ k_C C^* + b_C F^* = p_C + k_G G $$\nSubstitute for $C^*$:\n$$ k_C \\left[ \\frac{1}{p_A} \\left( b_A + \\frac{k_A k_F}{p_F} \\right) F^* \\right] + b_C F^* = p_C + k_G G $$\nFactor out $F^*$ from the left-hand side:\n$$ F^* \\left[ \\frac{k_C}{p_A} \\left( b_A + \\frac{k_A k_F}{p_F} \\right) + b_C \\right] = p_C + k_G G $$\nNow, we solve for $F^*$:\n$$ F^* = \\frac{p_C + k_G G}{b_C + \\frac{k_C}{p_A} \\left( b_A + \\frac{k_A k_F}{p_F} \\right)} $$\nTo present this as a single fraction, we simplify the denominator:\n$$ \\text{Denominator} = b_C + \\frac{k_C b_A}{p_A} + \\frac{k_C k_A k_F}{p_A p_F} $$\nThe common denominator for these terms is $p_A p_F$.\n$$ \\text{Denominator} = \\frac{b_C p_A p_F}{p_A p_F} + \\frac{b_A k_C p_F}{p_A p_F} + \\frac{k_A k_C k_F}{p_A p_F} = \\frac{b_C p_A p_F + b_A k_C p_F + k_A k_C k_F}{p_A p_F} $$\nSubstituting this back into the expression for $F^*$:\n$$ F^* = \\frac{p_C + k_G G}{\\frac{b_C p_A p_F + b_A k_C p_F + k_A k_C k_F}{p_A p_F}} $$\nInverting the denominator and multiplying gives the final closed-form expression:\n$$ F^* = \\frac{(p_C + k_G G) p_A p_F}{b_C p_A p_F + b_A k_C p_F + k_A k_C k_F} $$\nThis expression represents the steady-state cortisol concentration as a function of the gut inflammation drive $G$ and the system parameters, as required.", "answer": "$$\\boxed{\\frac{(p_C + k_G G) p_A p_F}{b_C p_A p_F + b_A k_C p_F + k_A k_C k_F}}$$", "id": "2844286"}]}